Prophylactic antibiotic therapy after inhalation injury

Burns. 2014 Dec;40(8):1476-80. doi: 10.1016/j.burns.2014.01.022. Epub 2014 Mar 12.

Abstract

Objective: Inhalation injury is suspected in patients with facial and neck burn-injuries and in patients who suffered burns in an enclosed space. Inhalation injury is associated with a disappointingly high morbidity and mortality in spite of advances in diagnostics and therapy.Prophylactic antibiotic therapy in patients with diagnosed inhalation injury is still a controversial subject.The epidemiologic characteristics of the burn patients with diagnosed inhalation injury in our clinic receiving prophylactic antibiotic therapy and mortality of these patients will be referred in this study.

Methods: Patients >16 years of age admitted to the burn unit between January 2008 and December 2012 and fulfilling the burn center referral criteria according the German Burn Association were enrolled in the study.

Results: 58 patients (male:female 47:11) were diagnosed with an inhalation injury by their admission. The average length of hospital stay was 27.5 days, whereas of the patients with no inhalation injury was 16 days (p=0.04). 56.9% of the patients underwent tracheostomy. An escalation of the antibiotic therapy was done in 39.7% of the patients with inhalation injury and in 20.3% of the patients without one. The mortality of inhalation injury patients was 12.1%.

Conclusions: The development of pneumonia is not influenced in a statistical significant way by the use of prophylactic antibiotics. We do recommend the administration of prophylactic antibiotic therapy to patients with diagnosed inhalation trauma, as the mortality of these patients was lower in comparison to other studies.

Keywords: Antibiotic therapy; Inhalation injury; Mortality; Pneumonia.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anti-Bacterial Agents / therapeutic use*
  • Burn Units
  • Burns / complications
  • Burns / therapy
  • Burns, Inhalation / complications
  • Burns, Inhalation / diagnosis
  • Burns, Inhalation / therapy*
  • Case-Control Studies
  • Female
  • Humans
  • Length of Stay
  • Male
  • Middle Aged
  • Penicillanic Acid / analogs & derivatives*
  • Penicillanic Acid / therapeutic use
  • Piperacillin / therapeutic use
  • Piperacillin, Tazobactam Drug Combination
  • Pneumonia, Bacterial / complications
  • Pneumonia, Bacterial / prevention & control*
  • Respiration, Artificial*
  • Retrospective Studies
  • Tracheostomy
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • Piperacillin, Tazobactam Drug Combination
  • Penicillanic Acid
  • Piperacillin